Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial

Anton, Raymond F., Latham, Patricia, Voronin, Konstantin, Book, Sarah, Hoffman, Michaela, Prisciandaro, James, Bristol, Emily·2020·JAMA Internal Medicine
DOI 10.1001/jamainternmed.2020.0249

Cited by (186)

Items 101–186 of 186

  1. Review of Evidence-Based Strategies to Treat Alcohol Use Disorder
    Julie Worley · 2021 · Journal of Psychosocial Nursing and Mental Health Services
  2. Medikamente zur Behandlung von Abhängigkeitserkrankungen und abhängigem Verhalten
    Falk Kiefer, Otto Benkert · 2023 · Springer eBooks
  3. Novel halogenated gabapentin-derivative introduction (GDCB), anti-bacterial, anti-fungal, and neuronal cell toxicity assessments
    Zohreh Fateminia, Hossein Chiniforoshan, Alireza Abbasi, Pouneh Mokarram, Azam Habibi, Barzin Safarkoopayeh · 2025 · Journal of Molecular Structure
  4. Pharmacologic interventions for alcohol use disorder
    Jordan Menge, Bernadette Evitt · 2025 · JAAPA
  5. Early alcohol abstinence symptoms and the role of cumulative adversity
    Helen C Fox, Jorge Alcina, Scott M. Hyman, Verica Milivojevic, Rajita Sinha · 2025 · Alcoholism Clinical and Experimental Research
  6. Real-world impact of AUD pharmacotherapy on healthcare utilization, cost, and cost-effectiveness in the United States
    Chi Mai Nguyen, Hanna L. Blaney, Jing Su, Shihui Jiang, Yang Li, Yining Li, Samer Gawrieh, Wanzhu Tu, Suthat Liangpunsakul · 2026 · Hepatology
  7. An Emergency Department Nudge-Based Strategy to Screen and Treat Patients With Alcohol Misuse
    Jeffrey P. Ebert, Samantha C. Huo, Jeanmarie Perrone, Jeffrey Moon, Nikhil K. Mull, Emilia J. Flores, Laurel Adams, Arielle Berk, Hannah Dart, Nicole Hummel O’Donnell et al. · 2026 · Annals of Emergency Medicine
  8. Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction
    2021 · Frontiers research topics
  9. Evidence-Based Practices for Co-occurring Addiction and Mental Illness
    Christine Yuodelis‐Flores, Matthew Iles-Shih, Richard K. Ries · 2022 · Springer eBooks
  10. Types of addiction
    Michelle A. Carroll Turpin, Kevin C. Rowland, Charles Anugwom, Marina Arocha, Anthony Carona, Brianna I. Gonzalez, Geina Iskander, Sarah Snyder, Kennedi Wilson, Alan D. Kaye et al. · 2023 · Elsevier eBooks
  11. Off-label medications for addictive disorders
    Tyler S. Vanderhoof · 2023 · Current Psychiatry
  12. Investigating Therapeutic Targets for Alcohol Use Disorder: Pharmacological View of ClinicalTrials.gov Data
    Nasser M. Alorfi · 2025 · International Journal of General Medicine
  13. Alcohol Withdrawal Syndrome
    Amanda K. Ramsdell, Stephanie Chiao · 2024 · Psychiatry update
  14. Diagnosis and Management of Substance Use Disorders in Athletes
    Pamela Walters, Bradley Hillier, Filippo Passetti, Anju Soni, Ian H. Treasaden · 2021 · Advances in Psychiatry and Behavioral Health
  15. Changed Primary Outcome Between Trial Registration and Publication
    Robert Andrew Kleinman, Michael Joshua Ostacher · 2020 · JAMA Internal Medicine
  16. Baseline gut microbiome and metabolites are correlated with alcohol consumption in a zonisamide clinical trial of heavy drinking alcoholic civilians
    Liv R. Dedon, Hanshu Yuan, Jinhua Chi, Haiwei Gu, Albert J. Arias, Jonathan Covault, Yanjiao Zhou · 2024 · medRxiv
  17. Implementation of Screening, Brief Intervention, and Referral to Treatment (SBIRT) Training in Large Cohorts of Second Year Medical Students
    Joshua O. Willms, Lisa Popp, Betsy Jones, Franklyn Babb, Ronald L. Cook, Shruthiranjani Nedumaran, Andrew K. Littlefield, David R. M. Trotter · 2021 · Alcoholism Treatment Quarterly
  18. Concurrent opioid and alcohol withdrawal management
    Michelle D. Colvard · 2023 · Mental Health Clinician
  19. Association of acamprosate versus gabapentinoids with hospitalization and total mortality in alcohol use disorder
    Raj Shah, Kirsten A. Zelneronok, Richard Henriquez, Ishak A. Mansi · 2025 · Journal of Hospital Medicine
  20. Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease
    Wei Zhang, Soo Young Hwang, Jay Luther · 2025 · Current Gastroenterology Reports
  21. Medications for Alcohol Use Disorder: a Harm Reduction Perspective
    Jungjin Kim, Sarah A. Lavery, Victoria R. Votaw · 2025 · Current Addiction Reports
  22. Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials
    Kaitlin R. McManus, Lara A. Ray · 2026 · Expert Review of Clinical Pharmacology
  23. Substance Use Withdrawal and Detox Strategies That Work
    Julie Worley · 2021 · Journal of Psychosocial Nursing and Mental Health Services
  24. Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence
    Jingxi Zhang, Peilin Meng, Yao Yao, Huijie Zhang, Chuyu Pan, Chun’e Li, Yujing Chen, Zhen Zhang, Shiqiang Cheng, Li Liu et al. · 2022 · Journal of Addiction Medicine
  25. Bridging Neuroscience and Clinical Assessment in a Patient with Alcohol Use Disorder, Anxiety, and Trauma
    Manesh Gopaldas, Elizabeth A. Flook, Jennifer Urbano Blackford · 2024 · Journal of Psychiatric Practice
  26. Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report
    Dale Terasaki, Aimee Ellinwood, Dan White · 2024 · Substance Abuse Treatment Prevention and Policy
  27. Successful Synergistic Use of Gabapentin With Other Antiepileptic Drugs in the Management of Lance-Adams Syndrome Complicated by Alcohol Withdrawal Seizures: A Case Report
    Danial Chowdhury, Caitlin M. McCarthy · 2024 · Clinical Neuropharmacology
  28. Prevalence and Predictors of Non-Benzodiazepine Use in Patients with Alcohol Withdrawal Syndrome in United States Emergency Departments – a cross-sectional study
    Kirolos Zakhary, Sophia Bruno, Caleb A Myatt, Vidya Perera, Kerolese Saleh, Jacob Smearman, Madeline M. Yuzwa, Mate Michael Soric, Stephanie T. Zampino · 2024 · INNOVATIONS in pharmacy
  29. Management of alcohol use disorder in alcohol-related liver disease
    Mohammed Abusuliman, Yael Milgrom, Jessica Leigh Mellinger, Richard Parker · 2025 · Frontline Gastroenterology
  30. La gabapentine pour les troubles liés à la consommation d’alcool
    Justin Weresch, Jessica E. M. Kirkwood, Christina S. Korownyk · 2021 · Canadian Family Physician
  31. Care of the Alcoholic Patient
    Herbert L. Muncie, Garland Anderson II, Linda K Oge · 2022 · Springer eBooks
  32. Medikamente zur Behandlung von Abhängigkeitserkrankungen und abhängigem Verhalten
    Falk Kiefer, Otto Benkert · 2020 · Springer eBooks
  33. Treatment of severe tardive dyskinesia with concurrent administration of olanzapine, clonazepam, baclofen, and gabapentin: a case report
    Xiaoling Guo, Jiong Chen, Weixin Wang, Bo Jiang, Bo Liang · 2023 · Journal of International Medical Research
  34. Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities
    Ned H. Kalin · 2021 · American Journal of Psychiatry
  35. 2-Arachodonoylglycerol-mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice
    Amanda Morgan, Danielle N. Adank, Keenan Johnson, Emily Blunt, Sachin Patel · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Comparative effectiveness of gabapentin and pregabalin on reduction in alcohol use: A nationwide observational cohort study
    Tommy Gunawan, Joshua C. Gray, Mingjian Shi, Thomas S. Wingo, Aliza P. Wingo, David A. Fiellin, John Tazare, Mehdi Farokhnia, Lorenzo Leggio, Henry R. Kranzler et al. · 2026 · medRxiv
  37. Brain penetrant calcium channel blockers do not reduce alcohol consumption: Converging results from two large independent cohort studies using electronic health records
    Christopher T. Rentsch, Vanessa A. Palzes, Mingjian Shi, Michael R. Setzer, Samantha G. Malone, Andrea H. Kline‐Simon, Zachary Piserchia, Emma L. Winterlind, Lorenzo Leggio, Vincent Lo Re et al. · 2026 · medRxiv
  38. Changed Primary Outcome Between Trial Registration and Publication—Reply
    Raymond F. Anton, Michaela Hoffman · 2020 · JAMA Internal Medicine
  39. Top 2020 studies relevant to primary care
    Betsy Thomas, Samantha Moe, Christina S. Korownyk, Adrienne J. Lindblad, Michael R. Kolber, Jamie Falk, Allison Paige, Jennifer Potter, Anthony D. Train, Justin Weresch et al. · 2021 · Canadian Family Physician
  40. Principales études pertinentes aux soins primaires en 2020
    Betsy Thomas, Samantha Moe, Christina S. Korownyk, Adrienne J. Lindblad, Michael R. Kolber, Jamie Falk, Allison Paige, Jennifer Potter, Anthony D. Train, Justin Weresch et al. · 2021 · Canadian Family Physician
  41. Modernizing Withdrawal Management Services
    Victor Mocanu, Nicole Cowan, Jan Klimas, Keith Ahamad, Evan Wood · 2021 · The Canadian Journal of Addiction
  42. Relación entre los tipos de administración desleal y apropiación indebida: interpretación doctrinal y jurisprudencial
    Orlando Gómez González · 2009 · Cuadernos de Política Criminal
  43. Care of the Alcoholic Patient
    Herbert L. Muncie, Garland Anderson II, Linda K Oge · 2020 · Springer eBooks
  44. Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review
    Ian Hunter Rutkofsky, Kristy A Fisher, Clara L. Alvarez Villalba, Samuel Neuhut · 2020 · Cureus
  45. Illustration of a Novel Gut-Brain Axis of Alcohol Withdrawal, Withdrawal-Associated Depression, Craving and Alcohol-Severity Index in Alcohol Use Disorder Patients
    Vatsalya Vatsalya, Ranganathan Parthasarathy, Joris C. Verster, Amor Royer, Manasa Sagaram, Zarlakhta Zamani, Huirong Hu, Melanie L. Schwandt, Lorenzo Leggio, Maiying Kong et al. · 2022 · medRxiv
  46. Alcohol Use Disorders and Neurological Illnesses
    Lekhansh Shukla, Venkata Lakshmi Narasimha, Arun Kandasamy · 2022 · Springer eBooks
  47. Should we treat patients with chronic alcohol dependency by antiepileptics?
    Jana Zárubová · 2021 · Neurologie pro praxi
  48. Substance Use in HIV Populations
    Elizabeth H. David, Thanh Thuy Truong · 2021
  49. The place of gabapentinoids in providing specialized care to patients with mental and behavioral disorders according to the principles of evidence-based medicine (literature review)
    Lubov Markozova · 2022 · Ukrains kyi Visnyk Psykhonevrolohii
  50. SU-6656 attenuates alcohol dependence induced withdrawal syndrome in mice
    Ajeet Pal Singh, Ashish Kumar Sharma, Thakur Gurjeet Singh · 2022 · International Journal of Health Sciences
  51. Does gabapentin decrease alcohol use in patients with alcohol use disorder?
    Benjamin Beggs, Hina Usman, Molly Henson · 2022 · Evidence-Based Practice
  52. Gabapentin as a drug with a broad potential. Presentation of its use in medical conditions beyond the official registration
    Aleksandra Paulina Banasiak, Jakub Rafał Pierzchała, Katarzyna Bednarz, Jakub Kasprowicz, Patryk Banaś, Natalia Sobańska, Rafał Teichman, Justyna Adamus, Kamila Abram, Michał Hyjek · 2022 · Journal of Education Health and Sport
  53. Alcohol Use Disorders and Neurological Illnesses
    Lekhansh Shukla, Venkata Lakshmi Narasimha, Arun Kandasamy · 2022 · Springer eBooks
  54. Gabapentinoids: condemned without sufficient evidence?
    Udo Bonnet, Heath B. McAnally · 2023 · The Lancet Regional Health - Europe
  55. Reply to letter to the editor: Eliminating the benzos: A benzodiazepine-sparing approach to preventing and treating alcohol withdrawal syndrome
    Tamriage Martin, Kristin A. Rebo, Gregory R. Stettler, Robert Shayn Martin, Elizabeth Hodges Shilling, James Jason Hoth, Andrew M. Nunn, Mary Alyce McCullough, Preston Roy Miller · 2024 · The Journal of Trauma: Injury, Infection, and Critical Care
  56. Paroxysmal Sympathetic Hyperactivity
    Gary Galang, Anne Tita, Justin Louis Weppner, Amy Kathleen Wagner · 2024 · Springer eBooks
  57. Chapter 40. Gabapentin and Pregabalin
    Mark A. Frye, Katherine Marshall Moore, Alan F. Schatzberg · 2024 · American Psychiatric Association Publishing eBooks
  58. Anticonvulsant drugs for alcohol-related disorders
    Alicja Góral, Michał Czachajda, Krystian Żuk, Kamila Duszyńska, Karol Dolepski, Marta Lis-Sochocka · 2024 · Medycyna Ogólna i Nauki o Zdrowiu
  59. Efficacy of Gabapentin in the Treatment of Alcohol Use Disorder
    Radosław Zaucha, Magdalena Gajkiewicz, M Zajac, Julia Silldorff, Tomasz Fura, Marcin Dudek, Zuzanna Felińska, Oliwia Iszczuk, Stanisław Anczyk, Magdalena Jaskółka · 2024 · Quality in Sport
  60. Reducing 30-Day Readmissions in Patients With Alcohol Use Disorder
    Laveena Meriga, Kenneth Wofford, Christina Cardy · 2024 · The Journal for Nurse Practitioners
  61. Pharmacological Treatment of Substance Use Disorders
    A. Benjamin Srivastava, FRANCES RUDNICK LEVIN, Edward V. Nunes · 2024 · Springer eBooks
  62. Alcohol Abuse Disorder: Alcohol Withdrawal Syndrome
    Deepali Dixit, Marissa Grillo, Jessica Hu, Maria Cardinale-King · 2024 · Springer eBooks
  63. The Future of Alcohol Use Disorder Treatment and Research
    A. Benjamin Srivastava, Jonathan M. Wai · 2024 · Psychiatry update
  64. Substance Use Disorders
    Ibrahim M. Sablaban, Hassan Barada · 2025 · Advances in Psychiatry and Behavioral Health
  65. Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management
    Maxwell Lamb, Michelle D. Colvard, Jonathan F. Lister, Eric Johnson · 2025 · Mental Health Clinician
  66. Evaluating health-related quality of life and health resource utilization among Gabapentinoid users with substance use disorder in the US: Trends, co-prescriptions, and cost analysis
    Saba Dangpiaei, Mohammad Abdullah Al-Mamun · 2025 · Exploratory Research in Clinical and Social Pharmacy
  67. Increasing Alcohol Pharmacotherapy Prescribing Rates in Australia: Implementing Evidence‐Based Treatment for Alcohol Use Disorder
    Thileepan Naren, Dean Membrey, Paul MacCartney, Sandra Kuntsche, Megan Cook, Heng Jiang, Emmanuel N. Kuntsche · 2025 · Drug and Alcohol Review
  68. Post Liver Transplant Management and Outcomes in Alcohol-Related Liver Disease
    Mohammed Abusuliman, Yara Dababneh, Gerald Scott Winder, Jessica Leigh Mellinger · 2025 · Clinics in Liver Disease
  69. Associations Between Alcohol Use and Self-reported Pain: Insights From the 2020 National Health Interview Survey
    Ling Liu, Nasim Maleki · 2025 · Journal of Addiction Medicine
  70. Managing Alcohol Use Disorder in Alcohol-Related Liver Disease
    Mashal Khan, Sahil Anand, Akhil Shenoy · 2025 · Clinics in Liver Disease
  71. Chapter 3. Alcohol Use Disorder
    Henry R. Kranzler, Clifford M. Knapp, Emily E. Hartwell · 2025 · American Psychiatric Association Publishing eBooks
  72. Gabapentin exposures in those aged 50 years and older reported to United States poison centers: reasons for exposure and medical outcomes
    Namkee G. Choi, C. Nathan Marti, S. David Baker · 2026 · Clinical Toxicology
  73. Addictions: Everyone, everywhere, everything
    Long Hoang, Seth Judd · 2026 · Cambridge University Press eBooks
  74. The Problem of Monologic Approaches to Alcoholism
    Matthew S. Thatcher · 2025 · Springer eBooks
  75. Alcohol Withdrawal Seizures: Neurobiological Mechanisms, Clinical Predictors, and Evidence- Based Management
    Valentin Yurievich Skryabin, Alexandra Malygina, Svetlana I. Sokolova · 2026 · Journal of Psychiatric Practice
  76. Clinical study of the preventive effect of pulsed radiofrequency and continuous epidural block on postherpetic neuralgia: a randomized controlled trial
    Ping Xu, Yong Fei, Enming Zhang · 2026 · Frontiers in Pain Research
  77. High Prevalence of Unhealthy Alcohol Use Among Persons with HIV, Viral Non-suppression and Any Alcohol Use in Mbarara, Uganda: A Brief Report
    Rebecca J. Fisk-Hoffman, Allen Kekibiina, Winnie R. Muyindike, Huimin Cheng, Patrick Agumenaitwe, Ve Truong, Olivia Allison, Natalia Gnatienko, Judith I. Tsui, Judith A. Hahn et al. · 2026 · AIDS and Behavior
  78. Chapter 5. Alcohol Use and Use Disorder Among Older Adults
    Ganesh Gopalakrishna, Pallavi Joshi, Nisha Patel · 2024 · American Psychiatric Association Publishing eBooks
  79. Outpatient Phenibut Taper Supported by Baclofen and Gabapentin
    Paul Simon, Jason Yost · 2026 · Cureus
  80. Brain Reward Dopaminergic Circuits Involved in Sleep Deficiency, Sleep Deprivation and Relapse to Psychostimulants: A Narrative Review of Preclinical and Clinical Evidence
    Debora Yoaly Arana-Lechuga, Marcel Pérez-Morales, Óscar Sánchez-Escandón · 2026 · Current Behavioral Neuroscience Reports
  81. Prazosin-Related Reductions in Daily Craving Mediate Treatment-Related Daily Alcohol Use Outcomes in Alcohol Use Disorder
    Stephanie Wemm, Rachel Hart, Gretchen Hermes, Zachary M. Harvanek, Rajita Sinha · 2026 · Biological Psychiatry Global Open Science
  82. Medikamente zur Behandlung von Abhängigkeitserkrankungen und abhängigem Verhalten
    Falk Kiefer, Francesca Borlak · 2026 · Springer eBooks
  83. Alcohol
    Matthew E. Sloan, Angela Praecht, Robert B. Werner, Stephanie Yarnell-Mac Grory, Ismene L. Petrakis · 2026 · Springer eBooks
  84. Prazosin in the Pharmacologic Management of Alcohol Use Disorder
    Murray A. Raskind, Andrew J. Saxon, Tracy L. Simpson · 2026 · Biological Psychiatry Global Open Science
  85. Brain Penetrant Calcium Channel Blockers Were Not Associated With Reduced Alcohol Consumption: Converging Results From Two Large Independent Cohort Studies Using Electronic Health Records
    Christopher T. Rentsch, Vanessa A. Palzes, Mingjian Shi, Michael R. Setzer, Samantha G. Malone, Andrea H. Kline‐Simon, Zachary Piserchia, Emma L. Winterlind, Lorenzo Leggio, Vincent Lo Re et al. · 2026 · Pharmacoepidemiology and Drug Safety
  86. Gabapentinoids and Their Use in Alcohol Use Disorders
    Richard Henriquez, Ishak A. Mansi · 2026 · Springer eBooks